| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |